Pan-cancer analysis of YAP1 expression as a predictive biomarker for cancer immunotherapy | Caris Life Sciences
Home / Research / Publications / Pan-cancer analysis of YAP1 expression as a predictive biomarker for cancer immunotherapy

Publications

Pan-cancer analysis of YAP1 expression as a predictive biomarker for cancer immunotherapy

Key Finding:

Consistent with observations in small-cell lung cancer, YAP1 expression positively correlates with the ‘T-cell inflamed’ phenotype in 12 additional cancer types. 

Download Publication
Learn More
Name(Required)